Update on the Teratogenicity of Maternal Mycophenolate Mofetil


Mycophenolic acid (MPA) products, namely mycophenolate mofetil and mycophenolate sodium, are immunosuppressive medications used to prevent rejection in solid organ transplant recipients and to treat various autoimmune disorders. Mycophenolate therapy is considered to be teratogenic based on observational studies of pregnancies exposed to MPA, which… (More)
DOI: 10.1055/s-0035-1556743